| 482.58 12.71 (2.71%) | 06-28 00:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Anthem, Inc. is a U.S.-based health benefits corporation that operates through its various subsidiary companies. Its operations are structured across four main divisions: Commercial & Specialty Business, Government Business, IngenioRx, and a general 'Other' category. The company provides a wide array of network-based managed care health plans, catering to diverse clientele including large and small employer groups, individual consumers, and participants in the Medicaid and Medicare programs. Its comprehensive managed care portfolio encompasses various options such as Preferred Provider Organizations (PPOs), Health Maintenance Organizations (HMOs), Point-of-Service (POS) plans, traditional indemnity coverage, and hybrid models like consumer-driven health plans, alongside specialized hospital-only and limited benefit offerings. Furthermore, Anthem offers a suite of managed care services for self-funded clients, including claims administration, underwriting, stop-loss insurance, actuarial analysis, access to its provider network, medical and disease management programs, wellness initiatives, and other administrative support. Beyond core health plans, the company delivers various specialty insurance products and services, including pharmacy benefits management (PBM), dental, vision, life, and disability insurance, as well as personalized healthcare solutions powered by analytics. It also serves the federal government through the Federal Employee Program and functions as a licensed entity of the Blue Cross and Blue Shield Association. By the close of 2021, specifically December 31st, its affiliated health plans collectively covered 45 million medical members. Tracing its origins back to its founding in Indianapolis, Indiana, in 1944, the company was initially named WellPoint, Inc. before rebranding as Anthem, Inc. in December 2014.
Wed, 15 Jul 2026
Elevance Health Releases Q2 2026 Financial Results - AlphaStreet
Mon, 04 May 2026
Anthem / Elevance Health (ELV) Stock Price: The Cheapest Large-Cap in Healthcare - Bitget
Thu, 10 Mar 2022
U.S. health insurer Anthem plans to rebrand as Elevance Health - Reuters
Thu, 10 Mar 2022
Checking in with Anthem Stock Amid Rebranding - Schaeffer's Investment Research
Mon, 26 Jul 2021
Anthem CEO Breaks Down myNEXUS Acquisition, Touts At-Home Care Capabilities - Home Health Care News
Tue, 02 Feb 2021
Anthem Acquires MMM Holdings and Affiliates From InnovaCare Health - Summit Partners
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Plans
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|